Neurovascular Devices - Global Market Outlook (2017-2026)
According to Stratistics MRC, the Global Neurovascular Devices Market is accounted for $1.90 billion in 2017 and is expected to reach $4.35 billion by 2026 growing at a CAGR of 9.6% from 2017 to 2026. Some of the key factors influencing the market growth are favorable medical reimbursements, rising target patient population and enhanced effectiveness and better patient outcomes. Moreover, rising number of researches in neurovascular therapies and rising demand for minimally invasive procedures will provide ample opportunities for the growth of the market. However, commercialization across developing economies and lack of skilled neurosurgeons are hampering the market growth.
Neurological devices/Interventional neurology is the non-surgical specialty that uses minimally invasive, image guided techniques for the treatment of most complex and dangerous diseases of neck, brain, and spine. Neurovascular devices are extensively used for the treatment of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others. A variety of material such as nitinol, cobalt, platinum can be used in neurovascular devices to achieve the specialized characteristics for aneurysm repair and ischemic stroke prevention.
By Therapeutic Application, the Ischemic strokes segment is anticipated to grow during the forecast period due to growing patient pool suffering from ischemic stroke. Ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked by a blood clot. By geography, North America has the highest market growth during the forecast period due to high pervasiveness of brain aneurysms. In U.S, High prevalence of ischemic stroke and stenosis will influence the growth.
Some of the key players include Penumbra, Inc., Johnson & Johnson, Microport Scientific Corporation, Abbott Laboratories, Stryker Corporation, Medtronic PLC , Terumo Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Boston Scientific Corporation, LivaNova PLC, Kaneka Medix Corp, Integra Lifesciences, Asahi Intecc CO., LTD, and Integer Holdings Corporation.
Disease Pathologies Covered:
• Arteriovenous Malformation and Fistulas
• Ischemic Strokes
• Cerebral Aneurysms
• Stenosis
• Other Disease Pathologies
Processes Covered:
• Stenting Technique
• Neurothrombectomy Procedure
• Coiling Procedure Technique
• Cerebral Angiography Technique
• Flow Disruption Technique
Products Covered:
• Cerebral Balloon Angioplasty and Stenting Systems
• Support Devices
• Aneurysm Coiling & Embolization Devices
• Neurothrombectomy Devices
• Revascularization Devices
• Other Products
Therapeutic Applications Covered:
• Brain Aneurysm
• Cerebral Artery Stenosis
• Ischemic Strokes
• Hemorrhagic Stroke
• Other Therapeutic Applications
End Users Covered:
• Ambulatory Surgical Units
• Hospitals
• Clinics
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End user Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neurovascular Devices Market, By Disease Pathology
5.1 Introduction
5.2 Arteriovenous Malformation and Fistulas
5.3 Ischemic Strokes
5.4 Cerebral Aneurysms
5.5 Stenosis
5.6 Other Disease Pathologies
6 Global Neurovascular Devices Market, By Process
6.1 Introduction
6.2 Stenting Technique
6.3 Neurothrombectomy Procedure
6.4 Coiling Procedure Technique
6.5 Cerebral Angiography Technique
6.6 Flow Disruption Technique
7 Global Neurovascular Devices Market, By Product
7.1 Introduction
7.2 Cerebral Balloon Angioplasty and Stenting Systems
7.2.1 Embolic Protection Systems
7.2.1.1 Distal Filter Devices
7.2.1.2 Balloon Occlusion Devices
7.2.2 Carotid Artery Stents
7.3 Support Devices
7.3.1 Micro Guidewires
7.3.2 Micro Catheters
7.4 Aneurysm Coiling & Embolization Devices
7.4.1 Liquid Embolic Agents
7.4.2 Clippings
7.4.3 Embolic Coils
7.4.3.1 Coated Detachable Coils
7.4.3.2 Bare Detachable Coils
7.4.4 Coil Assist Stent
7.4.5 Coil Assist Balloon
7.5 Neurothrombectomy Devices
7.5.1 Suction and Aspiration Devices
7.5.2 Clot Retrieval Devices
7.5.3 Snares
7.6 Revascularization Devices
7.6.1 Flow Diversion Stents
7.6.2 Carotid Artery Stents
7.7 Other Products
7.7.1 Intracranial Stents
7.7.2 Stent Retrievers
8 Global Neurovascular Devices Market, By Therapeutic Application
8.1 Introduction
8.2 Brain Aneurysm
8.3 Cerebral Artery Stenosis
8.4 Ischemic Strokes
8.5 Hemorrhagic Stroke
8.6 Other Therapeutic Applications
9 Global Neurovascular Devices Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Units
9.3 Hospitals
9.4 Clinics
10 Global Neurovascular Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Penumbra, Inc.
12.2 Johnson & Johnson
12.3 Microport Scientific Corporation
12.4 Abbott Laboratories
12.5 Stryker Corporation
12.6 Medtronic PLC
12.7 Terumo Corporation
12.8 Merit Medical Systems, Inc.
12.9 W.L. Gore & Associates, Inc.
12.10 Boston Scientific Corporation
12.11 LivaNova PLC
12.12 Kaneka Medix Corp
12.13 Integra Lifesciences
12.14 Asahi Intecc CO., LTD
12.15 Integer Holdings Corporation
List of Tables
1 Global Neurovascular Devices Market Outlook, By Region (2016-2026) ($MN)
2 Global Neurovascular Devices Market Outlook, By Disease Pathology (2016-2026) ($MN)
3 Global Neurovascular Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2016-2026) ($MN)
4 Global Neurovascular Devices Market Outlook, By Ischemic Strokes (2016-2026) ($MN)
5 Global Neurovascular Devices Market Outlook, By Cerebral Aneurysms (2016-2026) ($MN)
6 Global Neurovascular Devices Market Outlook, By Stenosis (2016-2026) ($MN)
7 Global Neurovascular Devices Market Outlook, By Other Disease Pathologies (2016-2026) ($MN)
8 Global Neurovascular Devices Market Outlook, By Process (2016-2026) ($MN)
9 Global Neurovascular Devices Market Outlook, By Stenting Technique (2016-2026) ($MN)
10 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Procedure (2016-2026) ($MN)
11 Global Neurovascular Devices Market Outlook, By Coiling Procedure Technique (2016-2026) ($MN)
12 Global Neurovascular Devices Market Outlook, By Cerebral Angiography Technique (2016-2026) ($MN)
13 Global Neurovascular Devices Market Outlook, By Flow Disruption Technique (2016-2026) ($MN)
14 Global Neurovascular Devices Market Outlook, By Product (2016-2026) ($MN)
15 Global Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty and Stenting Systems (2016-2026) ($MN)
16 Global Neurovascular Devices Market Outlook, By Embolic Protection Systems (2016-2026) ($MN)
17 Global Neurovascular Devices Market Outlook, By Carotid Artery Stents (2016-2026) ($MN)
18 Global Neurovascular Devices Market Outlook, By Support Devices (2016-2026) ($MN)
19 Global Neurovascular Devices Market Outlook, By Micro Guidewires (2016-2026) ($MN)
20 Global Neurovascular Devices Market Outlook, By Micro Catheters (2016-2026) ($MN)
21 Global Neurovascular Devices Market Outlook, By Aneurysm Coiling & Embolization Devices (2016-2026) ($MN)
22 Global Neurovascular Devices Market Outlook, By Liquid Embolic Agents (2016-2026) ($MN)
23 Global Neurovascular Devices Market Outlook, By Clippings (2016-2026) ($MN)
24 Global Neurovascular Devices Market Outlook, By Embolic Coils (2016-2026) ($MN)
25 Global Neurovascular Devices Market Outlook, By Coil Assist Stent (2016-2026) ($MN)
26 Global Neurovascular Devices Market Outlook, By Coil Assist Balloon (2016-2026) ($MN)
27 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2016-2026) ($MN)
28 Global Neurovascular Devices Market Outlook, By Suction and Aspiration Devices (2016-2026) ($MN)
29 Global Neurovascular Devices Market Outlook, By Clot Retrieval Devices (2016-2026) ($MN)
30 Global Neurovascular Devices Market Outlook, By Snares (2016-2026) ($MN)
31 Global Neurovascular Devices Market Outlook, By Revascularization Devices (2016-2026) ($MN)
32 Global Neurovascular Devices Market Outlook, By Flow Diversion Stents (2016-2026) ($MN)
33 Global Neurovascular Devices Market Outlook, By Carotid Artery Stents (2016-2026) ($MN)
34 Global Neurovascular Devices Market Outlook, By Other Products (2016-2026) ($MN)
35 Global Neurovascular Devices Market Outlook, By Intracranial Stents (2016-2026) ($MN)
36 Global Neurovascular Devices Market Outlook, By Stent Retrievers (2016-2026) ($MN)
37 Global Neurovascular Devices Market Outlook, By Therapeutic Application (2016-2026) ($MN)
38 Global Neurovascular Devices Market Outlook, By Brain Aneurysm (2016-2026) ($MN)
39 Global Neurovascular Devices Market Outlook, By Cerebral Artery Stenosis (2016-2026) ($MN)
40 Global Neurovascular Devices Market Outlook, By Ischemic Strokes (2016-2026) ($MN)
41 Global Neurovascular Devices Market Outlook, By Hemorrhagic Stroke (2016-2026) ($MN)
42 Global Neurovascular Devices Market Outlook, By Other Therapeutic Applications (2016-2026) ($MN)
43 Global Neurovascular Devices Market Outlook, By End User (2016-2026) ($MN)
44 Global Neurovascular Devices Market Outlook, By Ambulatory Surgical Units (2016-2026) ($MN)
45 Global Neurovascular Devices Market Outlook, By Hospitals (2016-2026) ($MN)
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the above manner.
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.